Efficacy of mesalazine in combination with bifid triple viable capsules on ulcerative colitis and the resultant effect on the inflammatory factors

Pakistan journal of pharmaceutical sciences

Volumn 31, Issue 6, 2018, Pages 2891-2895

  Huang, Min ^a   Chen, Zhongqiong ^a   Lang, Chunhui ^a   Chen, Jianlong ^a   Yang, Biying ^a   Xue, Linglong ^b   Zhang, Yu ^b  

^a CHONGQING THREE GORGES UNIVERSITY   (China)

^b SHANXI MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

IL10 PROTEIN, HUMAN; INTERLEUKIN 10; INTERLEUKIN 8; MESALAZINE; PROBIOTIC AGENT; TUMOR NECROSIS FACTOR;

ADULT; BIFIDOBACTERIUM; BLOOD; COMBINATION DRUG THERAPY; CONTROLLED STUDY; ENTEROCOCCUS; FEMALE; HUMAN; LACTOBACILLUS ACIDOPHILUS; MALE; RANDOMIZED CONTROLLED TRIAL; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; ULCERATIVE COLITIS;

ADULT; BIFIDOBACTERIUM; COLITIS, ULCERATIVE; DRUG THERAPY, COMBINATION; ENTEROCOCCUS; FEMALE; HUMANS; INTERLEUKIN-10; INTERLEUKIN-8; LACTOBACILLUS ACIDOPHILUS; MALE; MESALAMINE; PROBIOTICS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 85059828633     PISSN: 1011601X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)